Abstract
Studies in the area of inflammation and metabolism have linked the development of obesity and diabetes with the increase of pro-inflammatory markers, characterizing a low-grade chronic inflammation state, mainly in adipose and liver tissue. Another important aspect has shown that molecules that have immunomodulatory activity can present therapeutic activity, in the control of metabolic dy…